Novel NK1 receptor antagonist

被引:0
|
作者
Terrett, N
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:501 / 501
页数:1
相关论文
共 50 条
  • [21] EVALUATION OF THE NK1 RECEPTOR ANTAGONIST SERLOPITANT IN PATIENTS WITH OVERACTIVE BLADDER
    Frenkl, Tara L.
    Seltzer, Olga
    Zhu, Haiyuan
    Reiss, Theodore F.
    Green, Stuart A.
    Green, Stuart A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 676 - 676
  • [22] INVESTIGATION INTO DIFFERENCES IN TACHYKININ NK1 RECEPTORS BETWEEN AND WITHIN SPECIES USING A PEPTIDE AND A NONPEPTIDE NK1 RECEPTOR ANTAGONIST
    BERESFORD, IJM
    IRELAND, SJ
    STABLES, JM
    STUBBS, CM
    BALL, D
    HAGAN, RM
    BIRCH, PJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 : P92 - P92
  • [23] Displacement of iodinated neurokinins by RO0676789, a novel NK1 receptor antagonist, in rat tissues
    Bhattacharya, A
    Pan, P
    Daniels, DV
    Ford, APDW
    Hoffmann, T
    Sleight, AJ
    Tzoumaka, E
    FASEB JOURNAL, 2003, 17 (04): : A636 - A636
  • [24] FR-113680 - A NOVEL TRIPEPTIDE SUBSTANCE-P ANTAGONIST WITH NK1 RECEPTOR SELECTIVITY
    MORIMOTO, H
    MURAI, M
    MAEDA, Y
    HAGIWARA, D
    MIYAKE, H
    MATSUO, M
    FUJII, T
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (01) : 123 - 126
  • [25] NK1 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (04) : 169 - 169
  • [26] FK-224, A NOVEL CYCLOPEPTIDE SUBSTANCE-P ANTAGONIST WITH NK1 AND NK2 RECEPTOR SELECTIVITY
    MORIMOTO, H
    MURAI, M
    MAEDA, Y
    YAMAOKA, M
    NISHIKAWA, M
    KIYOTOH, S
    FUJII, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 398 - 402
  • [27] NK1 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (04) : 191 - 191
  • [28] The NK1 Receptor Antagonist L822429 Reduces Heroin Reinforcement
    Barbier, Estelle
    Vendruscolo, Leandro F.
    Schlosburg, Joel E.
    Edwards, Scott
    Juergens, Nathan
    Park, Paula E.
    Misra, Kaushik K.
    Cheng, Kejun
    Rice, Kenner C.
    Schank, Jesse
    Schulteis, Gery
    Koob, George F.
    Heilig, Markus
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (06) : 976 - 984
  • [29] CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST
    GITTER, BD
    WATERS, DC
    THRELKELD, PG
    LOVELACE, AM
    MATSUMOTO, K
    BRUNS, RF
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (03): : 439 - 446
  • [30] Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin
    Kris, MG
    Radford, JE
    Pizzo, BA
    Inabinet, R
    Hesketh, A
    Hesketh, PJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (11) : 817 - 818